Tocilizumab (TCZ) in New-onset Type 1 Diabetes

Clinical trial NCT02293837 · COMPLETED

Trial details

NCT number: NCT02293837
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus New-onset Type 1 Diabetes Mellitus T1DM T1D

Start date: 2015-03-12
Primary completion: 2019-07-10
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.